Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LEMTRADA
- TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
- Autologous Transplant Targeted Against Crohn's
- Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia
- Pharmacogenetic Study in Patients With Relapsing Forms of Multiple Sclerosis Who Developed ITP After Receiving Lemtrada
- RCT Comparing Autologous Hematopoietic Stem Cell Transplantation Versus Alemtuzumab in MS
- A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMT
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
- Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential
- Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
- Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA
- Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects
- Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
- Belatacept Post Depletional Repopulation to Facilitate Tolerance
- Phase 2 Fludarabine, Cytoxan and FCCAM
in Untreated B-Cell Chronic Lymphocytic Leukemia
Clinical trials list
click for details